Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

BACKGROUND: Interferon and ribavirin have been used as therapeutic agents for chronic hepatitis C infection or C-compensated cirrhosis in the conventional treatment. Hepatitis C virus (HCV) -specific direct-acting antiviral agents that directly inhibit the growth process of HCV have been approved si...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pharm Health Care Sci
Asıl Yazarlar: Omotani, Sachiko, Ishizaka, Toshihiko, Inoue, Miki, Nishida, Koji, Yasui, Yukako, Hatsuda, Yasutoshi, Mukai, Junji, Myotoku, Michiaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114806/
https://ncbi.nlm.nih.gov/pubmed/32266075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-020-00162-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller